Please use this identifier to cite or link to this item:
|Title:||Reduced cortical cholinergic innervation measured using [18F]-FEOBV PET imaging correlates with cognitive decline in mild cognitive impairment.||Austin Authors:||Xia, Ying;Eeles, Eamonn;Fripp, Jurgen;Pinsker, Donna;Thomas, Paul;Latter, Melissa;Doré, Vincent ;Fazlollahi, Amir;Bourgeat, Pierrick;Villemagne, Victor L ;Coulson, Elizabeth J;Rose, Stephen||Affiliation:||Dementia & Neuro Mental Health Research Unit, UQCCR, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia..
School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia..
School of Medicine, Northside Clinical School, The Prince Charles Hospital, Brisbane, QLD, Australia..
The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, QLD, Australia..
Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia..
Internal Medicine Service, The Prince Charles Hospital, Brisbane, QLD, Australia..
School of Psychology, The University of Queensland, Brisbane, QLD, Australia..
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA..
Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia..
|Issue Date:||24-Mar-2022||metadata.dc.date:||2022||Publication information:||NeuroImage. Clinical 2022; 34: 102992||Abstract:||Dysfunction of the cholinergic basal forebrain (BF) neurotransmitter system, including cholinergic axon denervation of the cortex, plays an important role in cognitive decline and dementia. A validated method to directly quantify cortical cholinergic terminal integrity enables exploration of the involvement of this system in diverse cognitive profiles associated with dementia, particularly at a prodromal stage. In this study, we used the radiotracer [18F]-fluoroethoxybenzovesamicol (FEOBV) as a direct measure of cholinergic terminal integrity and investigated its value for the assessment of cholinergic denervation in the cortex and associated cognitive deficits. Eighteen participants (8 with mild cognitive impairment (MCI) and 10 cognitively unimpaired controls) underwent neuropsychological assessment and brain imaging using FEOBV and [18F]-florbetaben for amyloid-β imaging. The MCI group showed a significant global reduction of FEOBV retention in the cortex and in the parietal and occipital cortices specifically compared to the control group. The global cortical FEOBV retention of all participants positively correlated with the BF, hippocampus and grey matter volumes, but no association was found between the global FEOBV retention and amyloid-β status. Topographic profiles from voxel-wise analysis of FEOBV images revealed significant positive correlations with the cognitive domains associated with the underlying cortical areas. Overlapping profiles of decreased FEOBV were identified in correlation with impairment in executive function, attention and language, which covered the anterior cingulate gyrus, olfactory cortex, calcarine cortex, middle temporal gyrus and caudate nucleus. However, the absence of cortical atrophy in these areas suggested that reduced cholinergic terminal integrity in the cortex is an important factor underlying the observed cognitive decline in early dementia. Our results provide support for the utility and validity of FEOBV PET for quantitative assessment of region-specific cholinergic terminal integrity that could potentially be used for early detection of cholinergic dysfunction in dementia following further validation in larger cohorts.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/29687||DOI:||10.1016/j.nicl.2022.102992||ORCID:||0000-0002-8051-0558
|Journal:||NeuroImage. Clinical||PubMed URL:||35344804||PubMed URL:||https://pubmed.ncbi.nlm.nih.gov/35344804/||Type:||Journal Article||Subjects:||Basal forebrain
Mild cognitive impairment
|Appears in Collections:||Journal articles|
Show full item record
checked on Jun 7, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.